EEF2K and permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome: Since overexpression of eEF-2K in PaCa is suppressed by developmental siRNA based-therapies, identification of specific eEF-2K inhibitors could provide a significant tool for blocking PDAC local invasion.